Mangalam Drugs & Organics Limited
NSE: MANGALAM BSE: MANGALAM
NSE
29.95
-1.21 (-3.88%)
Prev Close
31.16
Open Price
30
Volume
63,821
Today Low / High
29.78 / 31.48
52 WK Low / High
22.8 / 103.99
Range
28 - 31
BSE
30.06
-1.19 (-3.81%)
Prev Close
31.25
Open Price
31.19
Volume
8,116
Today Low / High
29.9 / 31.19
52 WK Low / High
22.7 / 116
Range
29 - 32
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 29.95 (target range: 28 - 31), reflecting a change of -1.21 (-3.88318%). On the BSE, it is listed at 30.06 (target range: 29 - 32), showing a change of -1.19 (-3.808%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
24 Feb
30.00
-0.17%
23 Feb
31.05
0.35%
20 Feb
31.50
0.51%
19 Feb
32.11
-1.40%
18 Feb
32.28
-0.53%
17 Feb
31.60
1.93%
16 Feb
32.70
-2.97%
13 Feb
33.49
-2.39%
12 Feb
34.57
-1.91%
11 Feb
33.00
4.76%
10 Feb
32.61
2.05%
09 Feb
34.00
0.24%
06 Feb
33.01
8.27%
05 Feb
34.21
0.00%
04 Feb
36.01
0.00%
03 Feb
37.90
0.00%
02 Feb
32.68
10.47%
01 Feb
34.39
0.00%
30 Jan
36.20
0.00%
29 Jan
38.10
0.00%
28 Jan
40.10
0.00%
Mangalam Drugs & Organics Limited Graph
Mangalam Drugs & Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Mangalam Drugs & Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 29.95, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 30.06 | 30.36 | 27.32 - 33.40 |
| 30.66 | 24.53 - 36.79 | ||
| 30.96 | 21.67 - 40.25 | ||
| Bearish Scenario | 30.06 | 29.76 | 26.78 - 32.74 |
| 29.46 | 23.57 - 35.35 | ||
| 29.16 | 20.41 - 37.91 |
Overview of Mangalam Drugs & Organics Limited
ISIN
INE584F01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
231,638
Market Cap
474,056,028
Last Dividend
0
Official Website
IPO Date
2005-05-23
DCF Diff
53.42
DCF
-23
Financial Ratios Every Investor Needs
Stock Dividend of MANGALAM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2017-12-21 | December 21, 17 | 0.5 | 0.5 | 2017-12-22 | 2017-12-29 | 2017-12-12 |
| 2011-09-20 | September 20, 11 | 2 | 2 | |||
| 2006-09-19 | September 19, 06 | 0.2 | 0.2 | |||
| 2005-08-30 | August 30, 05 | 0.2 | 0.2 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 317.58 Cr | 167.37 Cr | 150.21 Cr | 0.4730 | 3.47 Cr | 40.59 Cr | 17.40 Cr | 6.72 Cr | 4.25 | 36.33 Cr | 0.0212 |
| 2024-03-31 | 367.35 Cr | 348.54 Cr | 18.81 Cr | 0.0512 | 3.27 Cr | 9.51 Cr | 1.06 Cr | -9.07 Cr | -5.73 | 17.49 Cr | -0.0247 |
| 2023-03-31 | 370.20 Cr | 341.42 Cr | 28.78 Cr | 0.0777 | 3.32 Cr | 9.25 Cr | 15.10 Cr | 1.27 Cr | 0.80 | 25.95 Cr | 0.0034 |
| 2022-03-31 | 447.37 Cr | 392.68 Cr | 54.69 Cr | 0.1222 | 2.96 Cr | 7.77 Cr | 35.57 Cr | 19.66 Cr | 12.42 | 45.18 Cr | 0.0439 |
| 2021-03-31 | 379.80 Cr | 282.13 Cr | 97.67 Cr | 0.2572 | 2.25 Cr | 6.24 Cr | 44.45 Cr | 27.97 Cr | 17.67 | 55.02 Cr | 0.0736 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.59 Cr | 366.42 Cr | 217.44 Cr | 148.9790 Cr | 96.23 Cr | 93.64 Cr | 138.80 Cr | 133.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 191.5994 Cr |
| 2024-03-31 | 1.19 Cr | 333.70 Cr | 197.91 Cr | 135.7930 Cr | 106.99 Cr | 105.81 Cr | 123.64 Cr | 129.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 164.0611 Cr |
| 2023-03-31 | 2.68 Cr | 359.63 Cr | 207.67 Cr | 151.9562 Cr | 88.55 Cr | 85.87 Cr | 137.47 Cr | 134.43 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 165.3575 Cr |
| 2022-03-31 | 1.95 Cr | 328.43 Cr | 177.86 Cr | 150.5614 Cr | 87.90 Cr | 85.96 Cr | 117.11 Cr | 129.21 Cr | 10.49 Cr | 0.00 Cr | 0.00 Cr | 130.1133 Cr |
| 2021-03-31 | 0.58 Cr | 264.11 Cr | 133.32 Cr | 130.7860 Cr | 69.71 Cr | 69.12 Cr | 58.59 Cr | 117.54 Cr | 0.00 Cr | 0.00 Cr | 0.22 Cr | 109.0776 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 42.5941 Cr | -19.4724 Cr | -21.7124 Cr | 22.3929 Cr | 1.4093 Cr | 2.5889 Cr | -20.2012 Cr | 6.7207 Cr | -6.7094 Cr | 0.0000 Cr | -15.1621 Cr |
| 2024-03-31 | 3.9126 Cr | -11.8274 Cr | 5.2267 Cr | -7.9201 Cr | -1.5011 Cr | 1.1796 Cr | -11.8327 Cr | -9.0717 Cr | 12.4869 Cr | 0.0000 Cr | 16.8876 Cr |
| 2023-03-31 | 39.5231 Cr | -22.1723 Cr | -16.6171 Cr | 11.6094 Cr | 0.7338 Cr | 2.6807 Cr | -27.9137 Cr | 2.2138 Cr | -3.8658 Cr | 0.0000 Cr | -20.3609 Cr |
| 2022-03-31 | 25.7091 Cr | -27.3257 Cr | 2.9793 Cr | -1.9599 Cr | 1.3627 Cr | 1.9469 Cr | -27.6690 Cr | 27.7330 Cr | 14.1411 Cr | 0.0000 Cr | -58.5180 Cr |
| 2021-03-31 | 27.5497 Cr | -31.2853 Cr | 2.6983 Cr | -3.8864 Cr | -1.0373 Cr | 0.5918 Cr | -31.4361 Cr | 39.5191 Cr | 13.4421 Cr | 0.0000 Cr | 6.2551 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 58.49 Cr | 56.82 Cr | 1.66 Cr | 0.0284 | -5.89 Cr | -9.84 Cr | -6.21 | -1.32 Cr | -0.1682 |
| 2025-09-30 | 49.26 Cr | 33.06 Cr | 16.20 Cr | 0.3289 | -7.47 Cr | -7.35 Cr | -4.64 | -2.81 Cr | -0.1491 |
| 2025-06-30 | 57.21 Cr | 45.73 Cr | 11.48 Cr | 0.2007 | -8.95 Cr | -13.80 Cr | -8.72 | -4.48 Cr | -0.2412 |
| 2025-03-31 | 72.78 Cr | 35.36 Cr | 37.41 Cr | 0.5141 | 5.45 Cr | 0.06 Cr | 0.04 | 9.61 Cr | 0.0008 |
| 2024-12-31 | 88.55 Cr | 50.93 Cr | 37.62 Cr | 0.4249 | 4.72 Cr | 1.29 Cr | 0.81 | 8.91 Cr | 0.0145 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.38 Cr | 6.30 Cr | 9.67 Cr | 18.10 Cr | 116.94 Cr | 152.78 Cr | 132.18 Cr | 316.72 Cr | 189.15 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.59 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -148.98 Cr |
| 2025-03-31 | 2.59 Cr | 0.00 Cr | 2.59 Cr | 40.17 Cr | 138.80 Cr | 198.98 Cr | 133.60 Cr | 366.42 Cr | 217.44 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -147.97 Cr |
| 2024-09-30 | 6.09 Cr | 0.00 Cr | 6.09 Cr | 26.74 Cr | 142.95 Cr | 200.97 Cr | 130.79 Cr | 364.11 Cr | 216.14 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -13.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 2.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,731.80 | ₹4,155,168,301,046.00 | ₹2,769,336.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,255.50 | ₹1,660,638,702,190.00 | ₹92,138.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,397.90 | ₹1,488,449,200,576.00 | ₹846,302.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,300.20 | ₹1,082,505,160,638.00 | ₹1,802,879.00 |
| Lupin Limited | LUPIN | ₹2,250.20 | ₹1,028,438,158,600.00 | ₹1,065,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹903.85 | ₹909,484,591,862.00 | ₹368,888.00 |
| Mankind Pharma Limited | MANKIND | ₹2,054.70 | ₹848,190,581,438.00 | ₹217,516.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,164.40 | ₹676,285,409,821.00 | ₹987,804.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,495.50 | ₹657,069,457,500.00 | ₹119,453.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,058.60 | ₹580,938,585,407.00 | ₹372,421.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,028.50 | ₹555,242,494,587.00 | ₹1,411,584.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,515.30 | ₹384,438,001,535.00 | ₹150,378.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,948.80 | ₹368,410,168,051.00 | ₹55,209.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,070.40 | ₹332,356,231,238.00 | ₹674,051.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,434.50 | ₹271,941,808,630.00 | ₹126,588.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,362.00 | ₹221,314,334,178.00 | ₹244,316.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,800.50 | ₹220,012,500,000.00 | ₹5,234.00 |
| Eris Lifesciences Limited | ERIS | ₹1,384.60 | ₹188,605,907,279.00 | ₹127,178.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,366.00 | ₹171,484,296,374.00 | ₹45,522.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹944.85 | ₹169,231,960,670.00 | ₹10,306,610.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹750.85 | ₹147,589,421,655.00 | ₹66,813.00 |
| Granules India Limited | GRANULES | ₹599.60 | ₹145,504,162,114.00 | ₹532,194.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹879.00 | ₹139,207,008,492.00 | ₹173,438.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,712.60 | ₹130,177,630,570.00 | ₹59,587.00 |
| Cohance Lifesciences Limited | COHANCE | ₹309.55 | ₹118,423,658,187.00 | ₹803,652.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹883.60 | ₹108,449,529,600.00 | ₹60,419.00 |
| Viyash Scientific Limited | VIYASH | ₹219.42 | ₹95,712,223,756.00 | ₹660,093.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,161.00 | ₹85,669,410,502.00 | ₹15,824.00 |
| Strides Pharma Science Limited | STAR | ₹861.00 | ₹79,360,706,754.00 | ₹126,250.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹483.70 | ₹74,055,465,455.00 | ₹170,943.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹320.55 | ₹62,693,751,119.00 | ₹180,158.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹690.90 | ₹62,628,212,661.00 | ₹146,064.00 |
| FDC Limited | FDC | ₹368.85 | ₹60,052,499,483.00 | ₹76,713.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹127.50 | ₹41,376,502,470.00 | ₹473,000.00 |
| Innova Captab Limited | INNOVACAP | ₹671.80 | ₹38,443,707,302.00 | ₹18,427.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹319.30 | ₹34,792,609,115.00 | ₹45,187.00 |
| Suven Life Sciences Limited | SUVEN | ₹148.96 | ₹33,884,527,040.00 | ₹164,413.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.50 | ₹33,724,265,000.00 | ₹71,369.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹647.90 | ₹32,860,908,130.00 | ₹51,609.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,882.30 | ₹31,131,387,935.00 | ₹7,493.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹281.10 | ₹28,189,412,437.00 | ₹74,640.00 |
Key Executives
General Manager
Bhanvesh Dinesh Naik
Gender: Not Specified
Year Born: 1979
General Manager
Rakesh Sakikram Srivastava
Gender: male
Year Born: 1974
President
Kamal Ishvarlal Vashi
Gender: Not Specified
Year Born: 1980
Whole-Time Director
Brijmohan Murlidhar Dhoot
Gender: male
Year Born: 1951
Chairman & MD
Govardhan Murlidhar Dhoot
Gender: male
Year Born: 1953
Head of Purchase
Yaduraj Dhoot
Gender: male
Year Born: 2000
Company Secretary & Compliance Officer
Anuradha Pandey
Gender: female
Year Born: 1993
Chief Operating Officer
Krishnapriya Nawal
Gender: female
Year Born: 1985
Senior Manager
Mansi Sidhinath Pathak
Gender: female
Year Born: 1979
FAQs about Mangalam Drugs & Organics Limited
Who is the CEO of the company?
The CEO is Govardhan Murlidhar Dhoot.
What is the current market price of the stock?
The current price is ₹29.95.
What is the 52-week price range?
The range is ₹22.8-103.99.
What is the market capitalization of the company?
The market capitalization is ₹47.41 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -1.53.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Mangalam Drugs & Organics Limited (ISIN: INE584F01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹47.41 crores and an average daily volume of 231,638 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.